Lactulose syrup in chronic Liver disease is given?

NORCET 3 - 2022 (Shift-1)

Pharmacology

Easy

Appeared in: NORCET 3 - 2022 (Shift-1)

Explanation

Lactulose is the mainstay treatment for preventing and managing hepatic encephalopathy, a neuropsychiatric complication of advanced liver disease.
It works by being fermented by gut bacteria in the colon, which acidifies the colonic contents.
This acidic environment converts absorbable ammonia (NH₃) into non-absorbable ammonium (NH₄⁺), which is then trapped in the gut.
Lactulose also has an osmotic laxative effect, which increases stool frequency (aiming for 2-3 soft stools per day) to expel the trapped ammonia from the body, thereby lowering blood ammonia levels.

Option B: Lactulose does not prevent diarrhea; it causes it as part of its therapeutic effect. The goal is to induce 2-3 soft stools daily to eliminate ammonia.
Option C: Lactulose has no direct mechanism to prevent kidney damage. Its action is localized to the gastrointestinal tract to reduce ammonia levels.
Option D: Lactulose does not treat the underlying liver cirrhosis or prevent further hepatocellular damage. It only manages a complication of the existing liver failure.

Visual 1: Flowchart: Illustrating the mechanism of lactulose in hepatic encephalopathy. It would show lactulose entering the colon, being fermented by bacteria to create an acidic pH, which then converts NH₃ to NH₄⁺, followed by its excretion via laxative effect.
Visual 2: Infographic: Comparing absorbable ammonia (NH₃) and non-absorbable ammonium (NH₄⁺), highlighting how the change in pH 'traps' the toxin in the gut.

Clinical Relevance

Nursing practice connection: Knowing Pharmacotherapy for Hepatic Encephalopathy helps nurses interpret findings accurately and avoid errors in routine assessment, medication administration, and patient teaching.
A key nursing responsibility is to titrate the lactulose dose to achieve the target of 2-3 soft stools per day. This requires careful monitoring and patient education.
Nurses must closely monitor the patient's mental status (for signs of improving or worsening encephalopathy, like confusion or asterixis) and serum ammonia levels.
Monitoring for adverse effects such as severe diarrhea, dehydration, and electrolyte imbalances (hypokalemia, hypernatremia) is crucial for patient safety.

How to Approach the Question

First, identify the core components of the question: the drug (Lactulose syrup) and the patient's condition (chronic liver disease).
The question asks for the primary reason ('is given') for using this drug in this specific condition.
Recall the major complications of chronic liver disease. These include ascites, variceal bleeding, and hepatic encephalopathy.
Access your pharmacology knowledge. Think about the mechanism of action of lactulose. It's a non-absorbable sugar that acts as an osmotic laxative.
Connect the drug's action to the complications. The laxative effect and its ability to lower ammonia levels are directly targeted at managing hepatic encephalopathy.
Evaluate the options. Option A directly states this primary indication. Options B, C, and D are inconsistent with the drug's known mechanism and therapeutic goals in this context.

Concept Tested & Keywords

Q3wTInFbxSVGp1KJLIRa72